Evaluation of particle agglutination test for detection of HIV-I antibodies. 1993

J V Prakash, and P M Khare, and V Haridas
Department of Microbiology, Grant Medical College, Byculla, Bombay.

A commercially available particle agglutination test (PA) was evaluated for its specificity and sensitivity as compared to ELISA currently used in our laboratory to detect HIV-I antibodies. A total of 463 sera from blood donors and clinical referrals were screened by PA, 45 were found to be positive (9.7%). Out of 463, 258 sera were simultaneously screened by ELISA; 28 were found to be positive (10.8%). Twelve samples showing positive results by both ELISA & PA were tested by Western blot and were confirmed to be positive. We found sensitivity of PA as compared to ELISA as 100% and specificity to be 88.44%. Readings of PA taken at 2 hrs should be reconfirmed at 24 hrs as it eliminates a number of false positives. Overall, we feel PA is fairly comparable with ELISA. It can be used in the set up where equipment and trained personnel for ELISA are not available for primary screening purposes.

UI MeSH Term Description Entries
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005069 Evaluation Studies as Topic Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. Critique,Evaluation Indexes,Evaluation Methodology,Evaluation Report,Evaluation Research,Methodology, Evaluation,Pre-Post Tests,Qualitative Evaluation,Quantitative Evaluation,Theoretical Effectiveness,Use-Effectiveness,Critiques,Effectiveness, Theoretical,Evaluation Methodologies,Evaluation Reports,Evaluation, Qualitative,Evaluation, Quantitative,Evaluations, Qualitative,Evaluations, Quantitative,Indexes, Evaluation,Methodologies, Evaluation,Pre Post Tests,Pre-Post Test,Qualitative Evaluations,Quantitative Evaluations,Report, Evaluation,Reports, Evaluation,Research, Evaluation,Test, Pre-Post,Tests, Pre-Post,Use Effectiveness
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000372 Agglutination Tests Tests that are dependent on the clumping of cells, microorganisms, or particles when mixed with specific antiserum. (From Stedman, 26th ed) Agglutination Test,Test, Agglutination,Tests, Agglutination
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D015483 HIV Antibodies Antibodies reactive with HIV ANTIGENS. AIDS Antibodies,HIV-Associated Antibodies,HTLV-III Antibodies,HTLV-III-LAV Antibodies,LAV Antibodies,Lymphadenopathy-Associated Antibodies,T-Lymphotropic Virus Type III Antibodies, Human,HIV Associated Antibodies,HTLV III Antibodies,HTLV III LAV Antibodies,Lymphadenopathy Associated Antibodies,T Lymphotropic Virus Type III Antibodies, Human,Antibodies, AIDS,Antibodies, HIV,Antibodies, HIV Associated,Antibodies, HIV-Associated,Antibodies, HTLV III,Antibodies, HTLV-III,Antibodies, HTLV-III-LAV,Antibodies, LAV,Antibodies, Lymphadenopathy Associated,Antibodies, Lymphadenopathy-Associated
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human

Related Publications

J V Prakash, and P M Khare, and V Haridas
July 1988, Rinsho byori. The Japanese journal of clinical pathology,
J V Prakash, and P M Khare, and V Haridas
January 1988, Annales de l'Institut Pasteur. Virology,
J V Prakash, and P M Khare, and V Haridas
August 1988, Immunitat und Infektion,
J V Prakash, and P M Khare, and V Haridas
May 1988, Nihon rinsho. Japanese journal of clinical medicine,
J V Prakash, and P M Khare, and V Haridas
July 1992, Zhonghua yi xue za zhi = Chinese medical journal; Free China ed,
J V Prakash, and P M Khare, and V Haridas
October 1990, Medical laboratory sciences,
J V Prakash, and P M Khare, and V Haridas
April 1991, Japanese journal of cancer research : Gann,
J V Prakash, and P M Khare, and V Haridas
January 1992, Acta microbiologica Hungarica,
J V Prakash, and P M Khare, and V Haridas
September 1987, Diagnostic microbiology and infectious disease,
J V Prakash, and P M Khare, and V Haridas
January 1968, American journal of clinical pathology,
Copied contents to your clipboard!